IP Library Granted Patent US 11,051,514
Granted Patent B2
US 11,051,514 · App. 15/574,775 · Granted Jul 6, 2021

Antifungal compounds

Inventors: William J. Hoekstra (Durham, NC); Christopher M. Yates (Raleigh, NC); Robert J. Schotzinger (Raleigh, NC); Michael R. Loso (Carmel, IN); Gary D. Gustafson (Zionsville, IN); Michael T. Sullenberger (Westfield, IN); Kimberly Steward (Indianapolis, IN); Javier Delgado (Indianapolis, IN); Xuelin Wang (Carmel, IN)
Assignee: Mycovia Pharmaceuticals, Inc.
A01N43/653C07D401/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,051,514
App. No.
15/574,775
Granted
Jul 6, 2021
Kind
B2
Abstract

The present invention relates to compounds of Formula (I): wherein R 1 is as defined herein, or an acceptable salt, solvate, prodrug or hydrate thereof. The compounds of Formula I are inhibitors of metalloenzymes, such as lanosterol demethylase (CYP51).

Claims (17)

1. A compound of formula:

or an agriculturally or pharmaceutically acceptable salt, solvate or hydrate thereof.

2. A compound according to claim 1 , wherein the compound is:

4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile.

3. An agricultural composition comprising a compound according to claim 1 , or an agriculturally or pharmaceutically acceptable salt, solvate or hydrate thereof, and one or more agriculturally or phytologically acceptable excipients.

4. A method for the treatment of a metalloenzyme-mediated disease or disorder in a plant comprising applying to the plant a compound according to claim 1 , or an agricultural composition according to claim 3 .

5. The method according to claim 4 , wherein the metalloenzyme-mediated disease or disorder is a plant fungal disease or disorder.

6. The method according to claim 5 , wherein the plant fungal disease or disorder is caused by a plant fungal pathogen belonging to at least one genera selected from the group consisting of Blumeria, Podosphaera, Sphaerotheca, Uncinula, Erysiphe, Puccinia, Phakopsora, Gymnosporangium, Hemileia, Uromyces, Alternaria, Cercospora, Cladosporium, Cochliobolus, Colletotrichum, Magnaporthe, Mycosphaerella, Phaeosphaeria, Pyrenophora, Ramularia, Rhyncosporium, Septoria, Venturia, Ustilago, Aspergillus, Penicillium, Drechslera, Fusarium, Botrytis, Gibberella, Rhizoctonia, Pseudocercosporella, Sclerotinia, Helminthosporium, Stagonospora, Exserohilum , and Pyricularia.

7. The method according to claim 5 , wherein the plant fungal disease is selected from the group consisting of apple scab, speckled leaf blotch of wheat, leaf spot of sugarbeets, leaf spot of peanut, cucumber anthracnose, wheat leaf rust, grape powdery mildew, wheat powdery mildew, and black sigatoka.

8. The method according to claim 5 , wherein the plant fungal disease or disorder is caused by Venturia inaequalis, Septoria tritici, Cercospora beticola, Cercospora arachidicola, Colletotrichum lagenarium, Puccinia graminis f. sp. tritici, Uncinula necator, Blumeria graminis , or Mycosphaerella fijiensis.

9. A process for synthesizing the compound of claim 1 , the process comprising contacting a compound of Formula 1:

with sulfur in the presence of a suitable solvent to provide the compound of claim 1 :

10. A process according to claim 9 , wherein the solvent is N-methyl-2-pyrrolidinone.

11. A process according to claim 9 , wherein the reaction is carried out at a temperature within the range of 50 to 200° C.

12. A process according to claim 9 , wherein the reaction is carried out in an inert atmosphere.

13. The process according to claim 9 , further comprising reacting a compound of Formula D:

with 1H-1,2,4-triazole in the presence of potassium carbonate and dimethylsulfoxide, wherein the reaction is carried out at a temperature within a range of 15 to 60° C. in an inert atmosphere, to provide the compound of Formula 1:

Assignments (5)
CHANGE OF NAME Recorded May 24, 2021
From: VIAMET PHARMACEUTICALS (NC), INC.
To: MYCOVIA PHARMACEUTICALS, INC.
Reel/Frame 056351/0071 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: HOEKSTRA, WILLIAM J.; YATES, CHRISTOPHER M.; SCHOTZINGER, ROBERT J.
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 044802/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: LOSO, MICHAEL R.; GUSTAFSON, GARY D.; SULLENBERGER, MICHAEL; STEWARD, KIMBERLY; DELGADO, JAVIER; WANG, XUELIN
To: DOW AGROSCIENCES LLC
Reel/Frame 044802/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: DOW AGROSCIENCES LLC
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 044802/0716 →
CHANGE OF NAME Recorded Jan 2, 2018
From: VIAMET PHARMACEUTICALS, INC.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044978/0893 →
Continuity (2)
Provisional Application 62163106 · May 18, 2015
Related Publication 20190216087A1 · Jul 18, 2019